Ruxolitinib (topical)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ruxolitinib (topical), covering 2020-08-31 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Topical Ruxolitinib in Chronic Hand Dermatitis [Phase 1, Phase 2]